It is concluded that, in this heterologous expression system, 5-HT 1A receptors display`constitutive' activation of G-proteins and that spiperone displays inverse agonist activity whereas WAY 100,635 acts as a`neutral' antagonist at this site.
Introduction The study of G-protein-coupled receptors in heterologous expression systems has revealed that some ligands, referred to as`inverse agonists', inhibit the basal activity observed in second messenger or G-protein activation assays (Barker et al., 1994; Thomas et al., 1995) . On the assumption that endogenous agonist(s) are not present at the receptor, this action may be attributed to inhibition of endogenous or`constitutive' coupling/activation of the receptors themselves. This action has not, as yet, been investigated for the 5-HT 1A receptor, which is important as an autoreceptor in the control of 5-hydroxytryptaminergic transmission. The present study therefore addressed this issue by use of a Chinese hamster ovary cell line stably expressing human cloned 5-HT 1A receptors (CHO-5-HT 1A , Newman-Tancredi et al., 1992) . We examined the modulation of -tryphosphate) binding assays by 5-carboxamidotryptamine (5-CT), a prototypical 5-HT 1 receptor agonist, and spiperone, a classical 5-HT 1A receptor antagonist'. In addition, we tested the novel, 5-HT 1A -selective, silent' phenylpiperazine, N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)-cyclohexane-carboxamide (WAY 100,635; Fletcher et al., 1996; Newman-Tancredi et al., 1996) .
Methods CHO-5-HT 1A cells expressing approximately 1.6 pmol of human recombinant 5-HT 1A receptor mg 71 protein (Newman-Tancredi et al., 1992) were washed by resuspending in ice-cold Earle's Buered Saline Solution before centrifugation (450 g, 10 min, 48C). Cells were resuspended in buer A (HEPES (pH 7.4) 20 mM; MgSo 4 3 mM) and membranes were prepared by Polytron homogenization followed by 2 centrifugations at 48,000 g for 25 min at 48C. Membranes were resuspended in buer A and stored at 7808C. Ecacy was determined by measuring [ Incubations were terminated by rapid ®ltra-tion. Binding isotherms were analysed by non-linear regression and results are expressed as arithmetic means +s.e.mean of n (number in parentheses) determinations. pK b values were calculated according to Lazareno & Birdsall (1993) . 35 S]-GTPgS binding, when tested alone, but shifted the activation/ inhibition isotherms of 5-CT and spiperone to the right in a parallel manner, suggesting that WAY 100,635 competitively antagonizes both agonist and inverse agonist activity ( Figure  1a) . The pK b s calculated for WAY 100,635 were slightly higher for antagonism of 5-CT (9.77 and 10.05; see Results and legend to Table 1 ) than for antagonism of spiperone (9.02 and 9.32 nM). Whilst these values are in the same range as the pK i for WAY 100,635 at 5-HT 1A receptors (9.25, NewmanTancredi et al., 1996) it is possible that 5-CT and spiperone may stimulate/inhibit activation of dierent populations of intracellular G-proteins. Nevertheless, taken together, these data suggest that 5-HT 1A receptors constitutively activate Gproteins in CHO cells, an interpretation supported by the 3.6 fold increase in basal [ 35 S]-GTPgS binding between CHO-5-HT 1A membranes and control CHO membranes. The negative ecacy of spiperone shows that it has inverse agonist activity at CHO-5-HT 1A receptors, which is probably due to an induction or stabilization of an inactive conformation of 5-HT 1A receptors. This agrees with the observation that [ 3 H]-spiperone binds preferentially to G-protein-uncoupled 5-HT 1A receptors with an anity (pK i =7.76; Sundaram et al., 1993) (De Lean et al., 1982; Barker et al., 1994) . In contrast, the present data con®rm previous ®ndings that WAY 100,635, which is highly selective for 5-HT 1A receptors, exhibits no intrinsic agonist activity (Fletcher et al., 1996; Newman-Tancredi et al., 1996) and, in addition, demonstrate that WAY 100,635 is also devoid of inverse agonist activity at recombinant 5-HT 1A receptors.
In conclusion, the present data demonstrate the constitutive activity of recombinant human 5-HT 1A receptors and show that whilst spiperone is an inverse agonist at these sites, WAY 100,635 acts as a neutral antagonist, blocking both agonist and inverse agonist activity. 
